191 related articles for article (PubMed ID: 21737274)
21. Synthesis and antimycobacterial activity of azetidine-, quinazoline-, and triazolo-thiadiazole-containing pyrazines.
Bonde CG; Peepliwal A; Gaikwad NJ
Arch Pharm (Weinheim); 2010 Apr; 343(4):228-36. PubMed ID: 20205198
[TBL] [Abstract][Full Text] [Related]
22. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
Kristiansen M; Andersen B; Iversen LF; Westergaard N
J Med Chem; 2004 Jul; 47(14):3537-45. PubMed ID: 15214781
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.
Narayanaswamy VK; Nayak SK; Pillay M; Prasanna R; Coovadia YM; Odhav B
Chem Biol Drug Des; 2013 Feb; 81(2):219-27. PubMed ID: 23150983
[TBL] [Abstract][Full Text] [Related]
24. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
25. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors.
Panahi F; Yousefi R; Mehraban MH; Khalafi-Nezhad A
Carbohydr Res; 2013 Oct; 380():81-91. PubMed ID: 23978663
[TBL] [Abstract][Full Text] [Related]
27. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
[TBL] [Abstract][Full Text] [Related]
28. Synthetic studies in butenonyl C-glycosides: Preparation of polyfunctional alkanonyl glycosides and their enzyme inhibitory activity.
Bisht SS; Fatima S; Tamrakar AK; Rahuja N; Jaiswal N; Srivastava AK; Tripathi RP
Bioorg Med Chem Lett; 2009 May; 19(10):2699-703. PubMed ID: 19362832
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-mycobacterial activity of (E)-N'-(monosubstituted-benzylidene)isonicotinohydrazide derivatives.
Lourenço MC; Ferreira Mde L; de Souza MV; Peralta MA; Vasconcelos TR; Henriques Md
Eur J Med Chem; 2008 Jun; 43(6):1344-7. PubMed ID: 17923172
[TBL] [Abstract][Full Text] [Related]
30. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
31. Elucidation of Mycobacterium tuberculosis type II dehydroquinase inhibitors using a fragment elaboration strategy.
Tran AT; West NP; Britton WJ; Payne RJ
ChemMedChem; 2012 Jun; 7(6):1031-43. PubMed ID: 22461418
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P450(14DM) by molecular docking and MM/PBSA method.
Zampieri D; Mamolo MG; Vio L; Banfi E; Scialino G; Fermeglia M; Ferrone M; Pricl S
Bioorg Med Chem; 2007 Dec; 15(23):7444-58. PubMed ID: 17888669
[TBL] [Abstract][Full Text] [Related]
34. Bis dihydropyrimidine: synthesis and antimycobacterial activity.
Ali MA; Manogaran E; Govindasamy J; Sellappan V; Pandian S
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):149-53. PubMed ID: 20583864
[TBL] [Abstract][Full Text] [Related]
35. Multi-component synthesis of dihydropyrimidines by iodine catalyst at ambient temperature and in-vitro antimycobacterial activity.
Zalavadiya P; Tala S; Akbari J; Joshi H
Arch Pharm (Weinheim); 2009 Aug; 342(8):469-75. PubMed ID: 19565601
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents.
Ajay A; Singh V; Singh S; Pandey S; Gunjan S; Dubey D; Sinha SK; Singh BN; Chaturvedi V; Tripathi R; Ramchandran R; Tripathi RP
Bioorg Med Chem; 2010 Dec; 18(23):8289-301. PubMed ID: 21041091
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
Thomas KD; Adhikari AV; Chowdhury IH; Sandeep T; Mahmood R; Bhattacharya B; Sumesh E
Eur J Med Chem; 2011 Oct; 46(10):4834-45. PubMed ID: 21880400
[TBL] [Abstract][Full Text] [Related]
38. Novel class of hybrid natural products as antidiabetic agents.
Raj K; Misra N; Pachauri G; Sharma M; Tamrakar AK; Singh AB; Srivastava AK; Phani Kiran K; Narasimha Rao CV; Prubhu SR
Nat Prod Res; 2009; 23(1):60-9. PubMed ID: 19140071
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.
Srivastav NC; Rai D; Tse C; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 Aug; 53(16):6180-7. PubMed ID: 20718497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
